Targeted interventions may also be possible through treatment stratification on FADS genotypes, with the expectation that carriers of the C allele (the allele associated with higher PUFA desaturase activity and increased cancer risk) would obtain most benefit from interventions. This evidence concerns the gene PUM3 and cancer.